Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05624788 · ClinicalTrials.gov registry record
A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives
A clinical trial, sponsored by Genentech.
- Completed
- Registry status
- 84
- Enrollment target
NCT05624788: Completed study, sponsored by Genentech.
NCT05624788 is a clinical trial that has completed, run by Genentech. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05624788 has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indication requiring referral to one of the following specialists: neurologist, ophthalmologist, or oncologist. Eligible patients will have recently (≤6 months) been referred to a specialty care provider and not yet seen a specialist (in addition to meeting the other eligibility criteria). The PPD virtual site can enroll patients from anywhere across the United States. The study will collect data to determine whether a patient was seen by a specialist, diagnosed with a specialized disease, patient characteristics potentially associated with being seen or not seen by a specialist, and the reasons/barriers why a patient was not seen by a specialist through a number of patient surveys.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-12-02 |
| Est. Completion | 2025-04-15 |
What the finished NCT05624788 record still lists
NCT05624788 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05624788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05624788 about?
NCT05624788 is a clinical study titled "A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives". This is an observational study to define current care pathways for American Indian or Alaska Native patients who require specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indi...
What is the current status of trial NCT05624788?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2022-12-02. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT05624788?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05624788?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI